BioSyntech Files Preliminary Prospectus in Canada.Business Editors/Health/Medical Writers LAVAL, Quebec--(BUSINESS WIRE)--Jan. 14, 2004 BioSyntech, Inc (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BSYI) is pleased to announce that it has filed a preliminary prospectus Preliminary Prospectus A first draft registration statement filed by a firm prior to proceeding with an initial public offering of securities. The document, filed with the Securities & Exchange Commission, is intended to provide pertinent information to prospective shareholders with the regulatory authorities in the provinces of Quebec, Ontario, Manitoba, Alberta and British Columbia British Columbia, province (2001 pop. 3,907,738), 366,255 sq mi (948,600 sq km), including 6,976 sq mi (18,068 sq km) of water surface, W Canada. Geography , for the sale of a yet to be determined number of its common shares and warrants. The offering is being marketed through Canaccord Capital Corporation. In connection with this offering, BioSyntech has applied to list its common shares on a recognized Canadian Exchange. These securities have not and will not be registered under the United States Securities Act of 1933, as amended and subject to certain exemptions from registration, may not be offered or sold, or otherwise transferred, directly or indirectly, in the United States of America UNITED STATES OF AMERICA. The name of this country. The United States, now thirty-one in number, are Alabama, Arkansas, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Missouri, New Hampshire, , its territories or possessions, or to U.S. Persons. About BioSyntech - BioSyntech is a biotechnology company specializing in the discovery, development and manufacturing of regenerative medicine products and therapeutic delivery systems. BioSyntech's Quality Management System is registered to ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 9001:2000 and ISO 13485:2001.For additional information, visit www.biosyntech.com. THIS PRESS RELEASE CONTAINS CERTAIN "FORWARD-LOOKING" STATEMENTS, AS DEFINED IN THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and OF 1995 THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES. THERE CAN BE NO ASSURANCE THAT SUCH STATEMENTS WILL PROVE TO BE ACCURATE AND THE ACTUAL RESULTS AND FUTURE EVENTS COULD DIFFER MATERIALLY FROM MANAGEMENT'S CURRENT EXPECTATIONS. SUCH FACTORS ARE DETAILED FROM TIME TO TIME IN THE COMPANY'S FILINGS WITH THE REGULATORY AUTHORITIES HAVING JURISDICTION. NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion